Method for the in vitro screening of anti-cancer compounds...

Details Method for the in vitro screening of anti-cancer compounds... Method for the in vitro screening of anti-cancer compounds...

2007-08-03

2011-12-27

Aeder, Sean (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Reexamination Certificate

active

08084196

ABSTRACT:
The present invention relates to methods for the in vitro screening of an anti-metastatic compound that inhibits activity, methods for determining in vitro the presence or absence of a metastatic cancer in a subject by quantifying SK3 activity, methods for the in vitro assessment of the progression of the metastatic property of a cancer by quantifying SK3.

REFERENCES:
patent: 6165719 (2000-12-01), Chandy et al.
patent: 2002/0028808 (2002-03-01), Hansen
patent: 2002/0165379 (2002-11-01), Adelman et al.
patent: 2005/0272093 (2005-12-01), MacKinnon
patent: 2006/0024677 (2006-02-01), Morris et al.
Terstappen et al (Neuropharmacology, 2001, 40: 772-783).
Pedarzani et al (JBC, 2002, 277 (48): 46101-46109).
Shridhar et al (Oncogene, 2004, 23: 2206-2215).
Potier et al (Mol Cancer Ther, 2006, 5(11): 2946-2953).
International search report in corresponding PCT/EP2007/058052.
Terstappen G C et al., “Pharmacological characterisation of the human small conductance calcium-activated potassium channel HSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines”, Neuropharmacology, Pergamon Press, vol. 40, No. 6, 2001, pp. 772-783, XP001147580.
Terstappen G C et al., “The antidepressant fluoxetine blocks the human small conductance calcium-activated potassium channels SK1, SK2 and SK3”, Neuroscience Letters, Limerick, vol. 346, No. 1-2, Jun. 14, 2003, pp. 85-88, XP002302907.
Dale T J et al., “Partial apamin sensitivity of human small conductance CA2+-Activated K+ channels stably expressed in Chinese hamster ovary cells”, Naunyn-Schmiedeberg's Archives of Pharmacology, Springer, vol. 366, No. 5, Nov. 2002, pp. 470-477, XP009055049.
Vanderwinden, J-M., et al., “Kit-negative fibroblast-like cells expressing SK3, a Ca2+-Activated K+ channel, in the gut musculature in health and disease”, Cell Tissue Research, vol. 310, 2002, pp. 349-358, XP002428453.
Ouadid-Ahidouch H et al., “Cell-cycle-dependent expression of the large Ca<2+>-Activated K<+> channels in breast cancer cells”, Biochemical and Biophysical Research Communications, Academic Press Inc., vol. 316, No. 1, Mar. 26, 2004, pp. 244-251, XP004493167.
Roger S et al., “Description and role in proliferation of iberiotoxin-sensitive currents in different human mammary epithelial normal and cancerous cells”, Biochimica et Biophysica Acta., vol. 1667, No. 2, Dec. 15, 2004, pp. 190-199, XP004669640.
Potier, M., et al., “Identification of SK3 channel as a new mediator of breast cancer cell migration”, Molecular Cancer Therapeutics, vol. 5, No. 11, Nov. 2006, pp. 2946-2953, XP002428454.

Affiliated with

Also associated with

Rating

Method for the in vitro screening of anti-cancer compounds... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the in vitro screening of anti-cancer compounds..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the in vitro screening of anti-cancer compounds... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4269026